| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | See Remarks
1 company
Mahal Jeetinder Singh serves as a Chief Operating Officer at JSPR. Across recent SEC filings that breaks down to 0 buys and 5 sells. Those positions are worth an estimated $553K at current prices.
Historically, Mahal Jeetinder Singh's trades have earned a strong insider score of 73/100 across 5 rated trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +59.3%.
The biggest single holding is JSPR (~$553K) as Chief Operating Officer. The recent filings there lean toward selling, a net 12,600 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2024 | JSPR Jasper Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 900 | $22.11 | $19,899.00 | -3.5% | -73.7% | -91.4% | |
| Sep 12, 2024 | JSPR Jasper Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 900 | $21.23 | $19,103.67 | -3.5% | +4.7% | -88.7% | |
| Jun 12, 2024 | JSPR Jasper Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 900 | $24.16 | $21,739.50 | -3.5% | -15.5% | -76.8% | |
| Mar 12, 2024 | JSPR Jasper Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 900 | $26.44 | $23,792.22 | -3.5% | -7.9% | -79.3% | |
| Jun 13, 2023 | JSPR Jasper Therapeutics, Inc. | See Remarks | Sale+OE | 9,000 | $1.66 | $14,914.80 | -3.0% | -55.2% | +39.5% |